Delova Biotech

Delova Biotech is an emerging company focused on the development of improved new drugs for clinical needs, targeting dual filings in China and the U.S. Based on its proprietary XisGel® technology platform, the company has established a robust product pipeline. A series of improved non-opioid analgesics have now entered the preclinical development stage, aiming to provide patients with non-opioid, long-acting, and potent options to enhance human health through scientific innovation.